Nytt hopp för håravfall

Forskare i USA har av en händelse hittat en substans som ger stressade möss pälsen tillbaka. Nu hoppas de att substansen har samma effekt på människor.

Uppsala förser forskarvärlden med nytt verktyg

Med en ny multimetod kan forskare studera cellernas signalsystem i detalj. Metoden kan visa effekter av läkemedel och hur cancer uppstår.

Bio-Linux goes global

Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.

Seminar program Biotech Forum

Here is the entire seminar program at Biotech Forum September 28-29th

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.

Lund honours milieu enthusiast

Four professors at the University of Lund has appointed the milieu chief of the university as honorary doctor.

Nytt hopp om att behandla blodcancer

Forskare vid Uppsala universitet har gjort en upptäckt om blodcancertypen multipelt myelom som ger hopp om nya behandlingsmetoder.

En snyggare Biotechsweden.se

Opinion: Where do all the cool Swedish life science companies go?

It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Så hittar du uppköpskandidater

Att investera i bolag på börsen som kan bli uppköpta kan vara en investeringsstrategi att få en snabb avkastning på sitt investerade kapital.

Printing sensors for biological samples

Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...

Icke smittsamma sjukdomar - framtidens marknad

På senare tid har industrin mer och mer börjat använda sig av definitionen "icke smittsamma sjukdomar", på engelska non communicable diseases som förkortas NCD.

"An open mind is the key to successful meetings"

Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...

Storbolagen kan inte längre förlita sig på nya block busters

För vårt kära Astrazeneca var det kanske en av de viktigaste somrarna på många år. FDA lämnade besked om två viktiga produkter och dessutom genomfördes försäljn...

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.